Panthera tigris altaica (Amur tiger): 102954729
Help
Entry
102954729 CDS
T02988
Symbol
CASP3
Name
(RefSeq) caspase 3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
ptg
Panthera tigris altaica (Amur tiger)
Pathway
ptg01524
Platinum drug resistance
ptg04010
MAPK signaling pathway
ptg04115
p53 signaling pathway
ptg04148
Efferocytosis
ptg04210
Apoptosis
ptg04215
Apoptosis - multiple species
ptg04623
Cytosolic DNA-sensing pathway
ptg04650
Natural killer cell mediated cytotoxicity
ptg04657
IL-17 signaling pathway
ptg04668
TNF signaling pathway
ptg04726
Serotonergic synapse
ptg04932
Non-alcoholic fatty liver disease
ptg04933
AGE-RAGE signaling pathway in diabetic complications
ptg04936
Alcoholic liver disease
ptg05010
Alzheimer disease
ptg05012
Parkinson disease
ptg05014
Amyotrophic lateral sclerosis
ptg05016
Huntington disease
ptg05020
Prion disease
ptg05022
Pathways of neurodegeneration - multiple diseases
ptg05132
Salmonella infection
ptg05133
Pertussis
ptg05134
Legionellosis
ptg05145
Toxoplasmosis
ptg05146
Amoebiasis
ptg05152
Tuberculosis
ptg05160
Hepatitis C
ptg05161
Hepatitis B
ptg05162
Measles
ptg05163
Human cytomegalovirus infection
ptg05164
Influenza A
ptg05165
Human papillomavirus infection
ptg05167
Kaposi sarcoma-associated herpesvirus infection
ptg05168
Herpes simplex virus 1 infection
ptg05169
Epstein-Barr virus infection
ptg05170
Human immunodeficiency virus 1 infection
ptg05200
Pathways in cancer
ptg05203
Viral carcinogenesis
ptg05205
Proteoglycans in cancer
ptg05206
MicroRNAs in cancer
ptg05210
Colorectal cancer
ptg05222
Small cell lung cancer
ptg05416
Viral myocarditis
ptg05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
ptg00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102954729 (CASP3)
04668 TNF signaling pathway
102954729 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
102954729 (CASP3)
09143 Cell growth and death
04210 Apoptosis
102954729 (CASP3)
04215 Apoptosis - multiple species
102954729 (CASP3)
04115 p53 signaling pathway
102954729 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
102954729 (CASP3)
04650 Natural killer cell mediated cytotoxicity
102954729 (CASP3)
04657 IL-17 signaling pathway
102954729 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
102954729 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102954729 (CASP3)
05206 MicroRNAs in cancer
102954729 (CASP3)
05205 Proteoglycans in cancer
102954729 (CASP3)
05203 Viral carcinogenesis
102954729 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
102954729 (CASP3)
05222 Small cell lung cancer
102954729 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
102954729 (CASP3)
05161 Hepatitis B
102954729 (CASP3)
05160 Hepatitis C
102954729 (CASP3)
05164 Influenza A
102954729 (CASP3)
05162 Measles
102954729 (CASP3)
05168 Herpes simplex virus 1 infection
102954729 (CASP3)
05163 Human cytomegalovirus infection
102954729 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
102954729 (CASP3)
05169 Epstein-Barr virus infection
102954729 (CASP3)
05165 Human papillomavirus infection
102954729 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
102954729 (CASP3)
05133 Pertussis
102954729 (CASP3)
05134 Legionellosis
102954729 (CASP3)
05152 Tuberculosis
102954729 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
102954729 (CASP3)
05145 Toxoplasmosis
102954729 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
102954729 (CASP3)
05012 Parkinson disease
102954729 (CASP3)
05014 Amyotrophic lateral sclerosis
102954729 (CASP3)
05016 Huntington disease
102954729 (CASP3)
05020 Prion disease
102954729 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
102954729 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102954729 (CASP3)
05416 Viral myocarditis
102954729 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
102954729 (CASP3)
04932 Non-alcoholic fatty liver disease
102954729 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
102954729 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
102954729 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
ptg01002
]
102954729 (CASP3)
Enzymes [BR:
ptg01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
102954729 (CASP3)
Peptidases and inhibitors [BR:
ptg01002
]
Cysteine peptidases
Family C14: caspase family
102954729 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
102954729
NCBI-ProteinID:
XP_007099078
UniProt:
A0A8C9KN14
LinkDB
All DBs
Position
Un
AA seq
277 aa
AA seq
DB search
MENSENSVDAKSIKNSETKIFHGSKSMDSGIYMDNSYKMDYPEMGLCIIINNKNFHESTG
MPSRSGTDVDAANLRETFTNLKYEVRNKNDLTREQIVALLDSVSREDHSKRSSFICVLLS
HGDEGIIYGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTED
DIACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCLMLRLYAHKLEFVHILTRVN
RKVALEFESFSLDSAFHGKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacagtgaaaactcagtggatgcaaaatccattaaaaattcagaaacaaagatc
ttccatggaagcaaatcaatggactctggaatatacatggacaacagttacaaaatggat
taccctgaaatgggtttatgtataataattaataataagaactttcatgaaagtaccggt
atgccgtctcggtctggtacagatgtggatgcggcgaacctccgagaaacattcacaaac
ttgaaatacgaagtcaggaataaaaacgatcttacacgcgaacaaattgtggcgttgctg
gacagtgtttctagagaagatcatagcaaaaggagcagttttatttgcgtgcttctaagc
cacggtgatgaaggaatcatttatggaacaaacggacctgttgacctgaaaaaattgaca
ggtttcttcagaggggattattgtagaagtctaaccggcaaacccaaactcttcattatt
caggcctgccgaggcacggaactggactgcggcattgagactgacagtggtaccgaggat
gacatcgcctgccagaaaataccagtggaagccgacttcttatatgcgtattccacagcc
cctggttactactcctggcgaaattccaaggatggatcctggttcatccagtcactttgc
ttgatgctcagactgtatgctcacaagcttgagttcgtgcacattcttactcgggttaac
cgaaaggtagctctagaatttgagtccttttctcttgactctgcttttcatggaaagaaa
cagattccatgtattgtgtctatgctcacaaaagaactatatttttatcactga
DBGET
integrated database retrieval system